Zenas BioPharma Balance Sheet (2023-2026) | ZBIO

Balance Sheet Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & Equivalents (Quarter) 72.31M56.86M37.15M183.93M360.04M319.74M314.20M44.01M301.60M110.64M500.22M673.90M
Short-term Investments (Quarter) 0.09M0.09M0.09M31.02M115.83M229.27M175.32M232.55M216.98M446.55M
Cash & Current Investments (Quarter) 72.31M56.86M37.24M184.02M360.13M350.77M430.02M273.28M476.92M343.19M717.21M1,120.45M
Prepaid Assets (Quarter) 2.95M6.98M5.07M5.43M5.32M5.76M7.98M12.96M10.67M
Current Assets (Quarter) 59.80M393.78M355.92M317.81M278.60M296.64M351.17M730.16M653.79M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.19M0.15M0.18M0.07M0.06M0.05M0.03M0.03M0.02M
Long-Term Investments (Quarter) 1.83M1.61M10.72M17.27M1.34M30.76M
Long-Term Deferred Tax (Quarter) 1.40M0.84M0.71M0.44M0.49M
Other Non-Current Assets (Quarter) 0.09M5.79M0.09M12.86M0.21M11.71M0.08M13.81M14.54M16.29M
Non-Current Assets (Quarter) 8.38M9.65M14.04M15.96M14.48M25.38M32.47M17.52M47.90M
Assets (Quarter) 68.18M403.43M369.97M333.77M293.08M322.02M383.64M747.68M701.69M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 5.40M15.08M17.14M20.02M7.93M6.44M7.11M8.94M7.59M
Payables (Quarter) 5.40M15.08M17.14M20.02M7.93M6.44M7.11M8.94M7.59M
Accumulated Expenses (Quarter) 17.31M28.53M8.31M3.38M44.52M8.76M13.08M5.62M57.41M
Other Accumulated Expenses (Quarter) 0.11M0.33M0.25M0.38M0.51M0.58M0.87M0.94M0.77M
Current Leases (Quarter) 0.56M0.38M0.79M0.91M0.79M0.62M1.11M1.04M0.82M
Current Taxes (Quarter) 0.30M0.21M0.01M0.12M0.12M
Total Current Liabilities (Quarter) 23.26M44.00M57.29M49.13M53.24M52.42M62.65M61.16M65.82M
Non-Current Liabilities
Non-Current Debt (Quarter) 72.99M78.64M72.08M222.96M
Convertible Debt (Quarter) 20.30M
Preferred Stock Liabilities (Quarter) 193.29M250.09M193.29M199.53M
Operating Leases (Quarter) 0.26M0.22M0.32M0.21M0.18M0.21M0.08M0.02M
Other Non-Current Liabilities (Quarter) 20.30M
Total Non-Current Liabilities (Quarter) 23.52M0.22M73.17M78.85M350.69M388.77M
Total Liabilities (Quarter) 43.81M44.00M57.51M49.45M53.46M125.59M141.50M411.85M454.59M
Shareholder's Equity
Total Debt (Quarter) 72.99M78.64M72.08M222.96M
Common Equity (Quarter) -202.23M-225.72M-252.50M-288.78M359.44M312.46M284.32M239.63M196.43M242.14M335.83M247.10M
Liabilities and Shareholders Equity (Quarter) 68.18M403.43M369.97M333.77M293.08M322.02M383.64M747.68M701.69M
Retained Earnings (Quarter) 0.04M-334.79M0.19M705.14M-0.09M-524.70M-0.06M-846.12M1,205.80M
Treasury Shares (Quarter) 81.24M17.59M81.24M116.28M0.51M0.53M0.60M0.67M1.26M